We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$587M
2
NXPI icon
NXP Semiconductors
NXPI
+$554M
3
META icon
Meta Platforms (Facebook)
META
+$449M
4
INTU icon
Intuit
INTU
+$433M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$428M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTT
3026
DELISTED
GTT Communications, Inc.
GTT
$474K ﹤0.01%
132,950
-2,951
-2% -$12.7K
EBMT icon
3027
Eagle Bancorp Montana
EBMT
$190M
$465K ﹤0.01%
21,952
+11,893
+118% +$241K
GENC icon
3028
Gencor Industries
GENC
$212M
$465K ﹤0.01%
37,797
+6,265
+20% +$75.7K
SAMG icon
3029
Silvercrest Asset Management
SAMG
$79.9M
$463K ﹤0.01%
33,325
+887
+3% +$11.3K
AVEO
3030
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$463K ﹤0.01%
80,268
+18,632
+30% +$107K
TYME
3031
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$462K ﹤0.01%
378,776
+11,716
+3% +$12K
ALGS icon
3032
Aligos Therapeutics
ALGS
$34.9M
$458K ﹤0.01%
+662
New +$322K
FCAP icon
3033
First Capital
FCAP
$214M
$458K ﹤0.01%
7,569
– –
AVTX icon
3034
Avalo Therapeutics
AVTX
$983M
$457K ﹤0.01%
60
+1
+2% +$6.95K
ALR
3035
DELISTED
AlerisLife Inc
ALR
$457K ﹤0.01%
66,294
+18,290
+38% +$106K
CMCT
3036
Creative Media & Community Trust
CMCT
$13M
$456K ﹤0.01%
1
– –
ELMD icon
3037
Electromed
ELMD
$349M
$452K ﹤0.01%
46,086
+21,370
+86% +$201K
CRD.A icon
3038
Crawford & Co Class A
CRD.A
$669M
$451K ﹤0.01%
61,031
+3,011
+5% +$21.8K
TLPH icon
3039
Talphera
TLPH
$74.2M
$451K ﹤0.01%
18,171
+88
+0.5% +$2.69K
ESSA
3040
DELISTED
ESSA Bancorp
ESSA
$447K ﹤0.01%
29,831
+291
+1% +$4.18K
PBIP
3041
DELISTED
Prudential Bancorp, Inc.
PBIP
$446K ﹤0.01%
32,218
-115
-0.4% -$1.45K
MLSS icon
3042
Milestone Scientific
MLSS
$42.6M
$445K ﹤0.01%
209,760
+39,821
+23% +$70.1K
DHX icon
3043
DHI Group
DHX
$173M
$439K ﹤0.01%
197,810
+4,058
+2% +$8.32K
INZY
3044
DELISTED
Inozyme Pharma
INZY
$439K ﹤0.01%
21,292
+4,222
+25% +$101K
PAND
3045
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$438K ﹤0.01%
29,522
+19,241
+187% +$268K
ELOX
3046
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$435K ﹤0.01%
2,732
+37
+1% +$4.52K
ITRN icon
3047
Ituran Location and Control
ITRN
$1.05B
$433K ﹤0.01%
22,716
– –
MIRM icon
3048
Mirum Pharmaceuticals
MIRM
$6.14B
$433K ﹤0.01%
24,811
-135
-0.5% -$2.65K
AC
3049
DELISTED
Associated Capital Group
AC
$429K ﹤0.01%
12,218
-46
-0.4% -$1.64K
ORGS
3050
DELISTED
Orgenesis Inc. Common Stock
ORGS
$428K ﹤0.01%
9,509
+273
+3% +$13.2K
120 121
122
123 124

Similar funds

Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.